What to make of the correction?

The dream run has ended with a big thud. At least for the time being that is. And the bulls have been halted in their tracks. Yesterday's correction has taken the Sensex lower by 11% in just a couple of weeks. Not that this rally that started in March 2009 has been completely unidirectional. There have been a couple of corrections before as well. But at 11%, the current one is indeed the steepest. And with the memory of that terrible decline in the aftermath of the financial crisis still fresh, investors may not want to take chances. They may want to jump onto the selling bandwagon. However, we have reasons to believe that why this correction could present a fantastic long term buying opportunity.

First, let us have a look at the fundamentals. It has now been proved beyond doubt that the Indian economy is extremely resilient. When enough capital is available, it grows at 8%-9% and when it is not available in plenty, it grows at 6%-7%. And this trend is likely to persist for many more years to come. And if the economy grows, corporate earnings follow suit. Thus, from a long term perspective, it's a cinch that corporate earnings in India will grow at 12%-15%. With earnings power increasing, stock prices should also follow suit.

However, with Indians still showing a fair degree of aversion to stocks, FIIs will have to continue to play a big role. And they are not likely to disappoint either. With India emerging as the few genuine growth stories in the world currently, it's inconceivable the FIIs turn a blind eye to India for a long time given that growth has become so hard to come by in developed economies. Thus, if you as an investor need to benefit from this India growth story, it is times such as these that present a great opportunity to buy fundamentally strong companies from a long-term perspective. So, don't panic and keep accumulating stocks that are a play on the India growth story and are available at reasonable valuations.

One investor who is making merry
While some investors may still be sitting on the fence, the one investor who's making full use of the current market conditions is the Oracle of Omaha, Warren Buffett. In a deal that could make its earlier investments in securities of companies like Goldman Sachs and GE look like peanuts, his cola to insurance conglomerate Berkshire Hathaway has decided to fork out a massive US$ 44 bn to buy the US rail road giant Burlington Northern Santa Fe Corp. This also makes it his biggest deal so far, trouncing the US$ 22 bn purchase of General Re back in 1998. It should be noted that Buffett already owns a small stake in the company. Indeed, as he himself described, the deal is an all-in wager on economic future of the United States.

For a man who wouldn't touch anything that does not have a sustainable competitive advantage, the rail road giant must surely be having something going for it. And if we were to follow his earlier rationale of buying a part stake in the rail road giant back then, he had mentioned that trains had started to become more competitive against trucks in the backdrop of higher fuel prices. Also, since it is very difficult right now for a new entrant to build railroads, the incumbent players can have all the market to themselves. Hmm, now that's some long-term moat, isn't it?
 
Volatility plagues markets


While strong buying activity in the previous two hours of trade led the indices to pare their losses and inch towards the dotted line, renewed selling pressure at higher levels once again took toll. While select software and pharma stocks are weighing heavy on the indices, energy, metals and telecom stocks are evincing interest from investors.

The BSE-Sensex and NSE-Nifty are trading in the negative, down by around 135 points and 35 points respectively. However, the BSE-Midcap and BSE-Smallcap indices are trading higher by around 1% each. The Rupee is trading at 47.14 to the Dollar.

FMCG stocks are trading mixed. While Godrej Consumer and Pidilite are finding favour, Colgate and Hindustan Unilever are trading weak. As per a leading business daily, Godrej Consumer Products (GCPL) is eyeing several acquisition opportunities globally and has outlined a budget of Rs 10 bn for the purpose. These acquisitions are in different markets. For instance, in Africa, it is exploring the possibility for acquisition in the hair colour and hair care segment, while in India, GCPL is eyeing the hair care and personal care categories.

It must be noted that on the international front, the company has seen a CAGR revenue growth of 94% in the last four years. It now exports to 33 countries and has done 4 acquisitions over these years. These include Keyline, Rapidol and Kinky and it recently acquired 49% stake in Godrej Sara Lee (GSL), which is a JV (49:51) JV between Godrej Group and Sara Lee Corporation USA. GSL is the market leader in household insecticides, air care and hair cream in India.

Pharma stocks are witnessing a mixed trend currently. While Wockhardt and Lupin are leading the pack of gainers, Sun Pharma and Cipla are in the red. Lupin is trading higher by 4% currently. Infact, the stock has more than doubled since the rally began in March. The company reported a good set of numbers in the June quarter and in the September quarter too it has done well with sales and profits growing by 25% YoY and 39% YoY respectively. Moreover, in the US markets, the company's focus has been on increasing the strength of its branded generics portfolio. This strategy has paid off handsomely as can be evinced from the 83% YoY growth in sales from this business during the quarter.

In our view, Lupin's focus on branded generics in the US market will enhance the company's performance from this region. Given that the US generics market is highly competitive with brutal price erosion, focusing on either niche or branded products is the way to have an edge over peers in terms of earning good revenues and profits. Such products have less competition and thereby not much price erosion which further enhances the revenue and profitability potential.
 
Back
Top